NON-SMALL CELL LUNG CARCINOMA (NSCLC)
Clinical trials for NON-SMALL CELL LUNG CARCINOMA (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CARCINOMA (NSCLC) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CARCINOMA (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cancer drug aims to outperform current standard in advanced disease
Disease control Recruiting nowThis study tests a new medicine called SCTB14 against the standard drug pembrolizumab as the first treatment for people with advanced non-small cell lung cancer that has not spread to the brain. About 246 adults with a specific tumor marker (TPS ≥10%) will receive either SCTB14 o…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA (NSCLC)
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Do lower chemo doses help or hurt older lung cancer patients?
Knowledge-focused Recruiting nowThis study looks at older adults (65+) with advanced non-small cell lung cancer who don't have certain gene changes. Researchers want to see if getting a lower dose of chemotherapy affects how long they live compared to the standard dose. The goal is to learn the best way to trea…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA (NSCLC)
Sponsor: University of Malaya • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC